Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Paediatric Respiratory Reviews
|
August 7, 2021
Vaccines for COVID-19: Where do we stand in 2021?
Ketaki Sharma, Archana Koirala, Katrina Nicolopoulos, et al.
Communicable Diseases Intelligence (2018)
|
May 25, 2026
ATAGI 2024 Annual Statement on Immunisation
Katrina Nicolopoulos, Catherine Tran, Clayton Chiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2016
Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014
Sanjay Jayasinghe, Rob Menzies, Clayton Chiu, et al.
BMC Public Health
|
December 24, 2005
An automated, broad-based, near real-time public health surveillance system using presentations to hospital Emergency Departments in New South Wales, Australia
David J Muscatello, Tim Churches, Jill Kaldor, et al.
Pediatrics
|
September 17, 2014
Parental Tdap boosters and infant pertussis: a case-control study
Helen E Quinn, Thomas L Snelling, Andrew Habig, et al.
Communicable Diseases Intelligence Quarterly Report
|
January 14, 2014
Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010
Latika Naidu, Clayton Chiu, Andrew Habig, et al.
Vaccine
|
November 1, 2015
Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children
Sanjay Jayasinghe, Clayton Chiu, Rob Menzies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 6, 2017
Systematic Review and Meta-analysis of Indirect Protection Afforded by Vaccinating Children Against Seasonal Influenza: Implications for Policy
J Kevin Yin, Anita E Heywood, Melina Georgousakis, et al.
Vaccine
|
May 9, 2015
Long term population impact of seven-valent pneumococcal conjugate vaccine with a "3+0″ schedule-How do "2+1″ and "3+1″ schedules compare?
Christopher Lowbridge, Peter B McIntyre, Robin Gilmour, et al.
Communicable Diseases Intelligence (2018)
|
October 29, 2021
ATAGI 2021 annual statement on immunisation Last updated: 19 September 2021
Catherine Tran, Clayton Chiu, Allen C Cheng, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Paediatric Respiratory Reviews
|
August 7, 2021
Vaccines for COVID-19: Where do we stand in 2021?
Ketaki Sharma, Archana Koirala, Katrina Nicolopoulos, et al.
Communicable Diseases Intelligence (2018)
|
May 25, 2026
ATAGI 2024 Annual Statement on Immunisation
Katrina Nicolopoulos, Catherine Tran, Clayton Chiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2016
Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014
Sanjay Jayasinghe, Rob Menzies, Clayton Chiu, et al.
BMC Public Health
|
December 24, 2005
An automated, broad-based, near real-time public health surveillance system using presentations to hospital Emergency Departments in New South Wales, Australia
David J Muscatello, Tim Churches, Jill Kaldor, et al.
Pediatrics
|
September 17, 2014
Parental Tdap boosters and infant pertussis: a case-control study
Helen E Quinn, Thomas L Snelling, Andrew Habig, et al.
Communicable Diseases Intelligence Quarterly Report
|
January 14, 2014
Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010
Latika Naidu, Clayton Chiu, Andrew Habig, et al.
Vaccine
|
November 1, 2015
Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children
Sanjay Jayasinghe, Clayton Chiu, Rob Menzies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 6, 2017
Systematic Review and Meta-analysis of Indirect Protection Afforded by Vaccinating Children Against Seasonal Influenza: Implications for Policy
J Kevin Yin, Anita E Heywood, Melina Georgousakis, et al.
Vaccine
|
May 9, 2015
Long term population impact of seven-valent pneumococcal conjugate vaccine with a "3+0″ schedule-How do "2+1″ and "3+1″ schedules compare?
Christopher Lowbridge, Peter B McIntyre, Robin Gilmour, et al.
Communicable Diseases Intelligence (2018)
|
October 29, 2021
ATAGI 2021 annual statement on immunisation Last updated: 19 September 2021
Catherine Tran, Clayton Chiu, Allen C Cheng, et al.
Page
of 4